Pulmonary hypertension (PH) describes heterogeneous population of patients with a mean
pulmonary arterial pressure> 20 mm Hg. Rarely, PH presents as a primary disorder but is …

Despite anti-retroviral therapy (ART), human immunodeficiency virus-1 (HIV)-related
pulmonary disease continues to be a major cause of morbidity and mortality for people living …

Despite recent therapeutic advances, pulmonary hypertension (PH) remains a fatal disease
due to the development of right ventricular (RV) failure. At present, no treatments targeted at …

Abstract The INHAND (International Harmonization of Nomenclature and Diagnostic Criteria
for Lesions Project (www. toxpath. org/inhand. asp) is a joint initiative of the Societies of …

Rationale: HIV-associated pulmonary arterial hypertension (PAH) is likely a more prevalent
noninfectious complication of AIDS than previously recognized. Furthermore, the majority of …

Antiretroviral therapy has improved longevity for HIV-infected persons, but long-term HIV
infection is now complicated by increased rates of chronic medical conditions including …

Severe pulmonary hypertension (PH) associated with vascular remodeling is a long-term
complication of HIV infection (HIV-PH) affecting 1/200 infected individuals vs. 1/200,000 …

Pulmonary hypertension is broadly recognized as a group of disorders that share the
common characteristic of an elevated mean pulmonary arterial pressure (≥ 25 mm Hg) …

With increases in the immunocompromised patient population and aging of the HIV+
population, the risk of serious fungal infections and their complications will continue to rise …

Pulmonary arterial hypertension (PAH) is increased in HIV, but its pathogenesis is not fully
understood. Nonhuman primates infected with simian immunodeficiency virus (SIV) or SIV …